What is the address of Dr Astrid Bourguignont Ophtalmo?

The registered office of Dr Astrid Bourguignont Ophtalmo is located at Rue Emile Vandervelde 76, 4317 Faimes.

Is Dr Astrid Bourguignont Ophtalmo still active?

Yes. According to the CBE (30 October 2026) Dr Astrid Bourguignont Ophtalmo is active, legal situation “Normale toestand”, started on 29 April 2010.

Is Dr Astrid Bourguignont Ophtalmo registered on Peppol?

Yes, Dr Astrid Bourguignont Ophtalmo is registered on the Peppol network with ID 0208:0825484549.

What is the enterprise number of Dr Astrid Bourguignont Ophtalmo?

The enterprise number of Dr Astrid Bourguignont Ophtalmo is BE0825484549.

When was Dr Astrid Bourguignont Ophtalmo founded?

Dr Astrid Bourguignont Ophtalmo was founded on 29 April 2010.

Who are the directors of Dr Astrid Bourguignont Ophtalmo?

According to the 2025 annual accounts, the directors of Dr Astrid Bourguignont Ophtalmo are: Astrid BOURGUIGNONT.

Is Dr Astrid Bourguignont Ophtalmo a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 April 2010; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr Astrid Bourguignont Ophtalmo make in 2025?

Dr Astrid Bourguignont Ophtalmo posted a profit after taxes of € 134,328 in financial year 2025.

What is the revenue of Dr Astrid Bourguignont Ophtalmo?

As a small company, Dr Astrid Bourguignont Ophtalmo is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 200,067.

Dr Astrid Bourguignont Ophtalmo (Private Limited)

Dossier Dr Astrid Bourguignont Ophtalmo, printed on 30 October 2026 from databakkes.be/en/0825484549/dr-astrid-bourguignont-ophtalmo. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr Astrid Bourguignont Ophtalmo from Faimes, company number BE0825484549, closed financial year 2025 with a result of € 134,328 after tax. For that financial year Dr Astrid Bourguignont Ophtalmo recorded a gross margin of € 200,067 and equity of € 348,255. Compared with financial year 2024, the result moved from € 148,191 to € 134,328. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Growing

€ 348,255

▲ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 134,328

▼ 9% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 259,719

▲ 22% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 121,438 paid out

90 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 9,921

▼ 47% vs 2024

€ 9,146 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 654

▲ 63% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 8,261

▲ 154% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 115,752 Gross margin 2022: € 115,752 First fiscal year in the series	€ 168,529 Gross margin 2023: € 168,529 ▲ 46% vs 2022 (€ 115,752) Favourable step	€ 215,088 Gross margin 2024: € 215,088 ▲ 28% vs 2023 (€ 168,529) Favourable step	€ 200,067 Gross margin 2025: € 200,067 ▼ 7% vs 2024 (€ 215,088) Unfavourable step	▼ 7%
Profit after taxes	€ 86,070 Profit after taxes 2022: € 86,070 First fiscal year in the series	€ 113,568 Profit after taxes 2023: € 113,568 ▲ 32% vs 2022 (€ 86,070) Favourable step	€ 148,191 Profit after taxes 2024: € 148,191 ▲ 30% vs 2023 (€ 113,568) Favourable step	€ 134,328 Profit after taxes 2025: € 134,328 ▼ 9% vs 2024 (€ 148,191) Unfavourable step	▼ 9%
Equity	€ 201,797 Equity 2022: € 201,797 First fiscal year in the series	€ 255,553 Equity 2023: € 255,553 ▲ 27% vs 2022 (€ 201,797) Favourable step	€ 335,365 Equity 2024: € 335,365 ▲ 31% vs 2023 (€ 255,553) Favourable step	€ 348,255 Equity 2025: € 348,255 ▲ 4% vs 2024 (€ 335,365) Favourable step	▲ 4%
Total debts	€ 76,084 Total debts 2022: € 76,084 First fiscal year in the series	€ 94,786 Total debts 2023: € 94,786 ▲ 25% vs 2022 (€ 76,084) Unfavourable step	€ 90,812 Total debts 2024: € 90,812 ▼ 4% vs 2023 (€ 94,786) Favourable step	€ 140,275 Total debts 2025: € 140,275 ▲ 54% vs 2024 (€ 90,812) Unfavourable step	▲ 54%
Cash	€ 100,812 Cash 2022: € 100,812 First fiscal year in the series	€ 179,875 Cash 2023: € 179,875 ▲ 78% vs 2022 (€ 100,812) Favourable step	€ 212,577 Cash 2024: € 212,577 ▲ 18% vs 2023 (€ 179,875) Favourable step	€ 259,719 Cash 2025: € 259,719 ▲ 22% vs 2024 (€ 212,577) Favourable step	▲ 22%
Retained profit	€ 189,397 Retained profit 2022: € 189,397 First fiscal year in the series	€ 243,153 Retained profit 2023: € 243,153 ▲ 28% vs 2022 (€ 189,397) Favourable step	€ 322,965 Retained profit 2024: € 322,965 ▲ 33% vs 2023 (€ 243,153) Favourable step	€ 335,855 Retained profit 2025: € 335,855 ▲ 4% vs 2024 (€ 322,965) Favourable step	▲ 4%
Dividend	€ 59,506 Dividend 2022: € 59,506 First fiscal year in the series	€ 59,812 Dividend 2023: € 59,812 ▲ 1% vs 2022 (€ 59,506) Unchanged	€ 68,379 Dividend 2024: € 68,379 ▲ 14% vs 2023 (€ 59,812) Unchanged	€ 121,438 Dividend 2025: € 121,438 ▲ 78% vs 2024 (€ 68,379) Unchanged	▲ 78%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 27,366 Bank debt 2023: € 27,366 Unchanged (€ 0) Unfavourable step	€ 18,782 Bank debt 2024: € 18,782 ▼ 31% vs 2023 (€ 27,366) Favourable step	€ 9,921 Bank debt 2025: € 9,921 ▼ 47% vs 2024 (€ 18,782) Favourable step	▼ 47%
Balance sheet total	€ 277,882 Balance sheet total 2022: € 277,882 First fiscal year in the series	€ 350,339 Balance sheet total 2023: € 350,339 ▲ 26% vs 2022 (€ 277,882) Unchanged	€ 426,177 Balance sheet total 2024: € 426,177 ▲ 22% vs 2023 (€ 350,339) Unchanged	€ 488,530 Balance sheet total 2025: € 488,530 ▲ 15% vs 2024 (€ 426,177) Unchanged	▲ 15%

Key figures of Dr Astrid Bourguignont Ophtalmo, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr Astrid Bourguignont Ophtalmo?

What happened at Dr Astrid Bourguignont Ophtalmo in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 134,328 (▼ 9% vs 2024). Source: NBB ↗
2023 Astrid BOURGUIGNONT became a director. NBB
Apr 29, 2010 Start of the company according to the CBE. KBO
Apr 28, 2010 New establishment in Faimes. KBO

In short

From € 86,070 profit in 2022 to € 134,328 profit in 2025.

Paid € 183,031 in corporate taxes since 2022.

Best year ever: 2024, with € 148,191 profit.

Paid out € 309,135 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Astrid BOURGUIGNONT

Dr Astrid Bourguignont Ophtalmo

Behind Dr Astrid Bourguignont Ophtalmo is Astrid BOURGUIGNONT.

Directors

According to the 2025 annual accounts

Astrid BOURGUIGNONT

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Emile Vandervelde 76

4317 Faimes

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0825.484.549
VAT number: BE 0825.484.549
Registered office: Rue Emile Vandervelde 76, 4317 Faimes
Names & denominations: Dr Astrid Bourguignont Ophtalmo
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 29 April 2010
Peppol: Active · Active since 12 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗